HK1213926A1 - 新穎重組博德特氏菌菌株 - Google Patents
新穎重組博德特氏菌菌株Info
- Publication number
- HK1213926A1 HK1213926A1 HK16101999.1A HK16101999A HK1213926A1 HK 1213926 A1 HK1213926 A1 HK 1213926A1 HK 16101999 A HK16101999 A HK 16101999A HK 1213926 A1 HK1213926 A1 HK 1213926A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- novel recombinant
- bordetella strains
- recombinant bordetella
- strains
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306279.6A EP2722338A1 (en) | 2012-10-17 | 2012-10-17 | Novel recombinant Bordetella strains |
| PCT/EP2013/071724 WO2014060514A1 (en) | 2012-10-17 | 2013-10-17 | Novel recombinant bordetella strains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1213926A1 true HK1213926A1 (zh) | 2016-07-15 |
Family
ID=47073385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16101999.1A HK1213926A1 (zh) | 2012-10-17 | 2016-02-23 | 新穎重組博德特氏菌菌株 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9528086B2 (zh) |
| EP (3) | EP2722338A1 (zh) |
| JP (3) | JP6473086B2 (zh) |
| CN (2) | CN104936976B (zh) |
| AU (1) | AU2013333928B2 (zh) |
| CA (1) | CA2887055C (zh) |
| DK (2) | DK2909229T3 (zh) |
| ES (2) | ES2771675T3 (zh) |
| HK (1) | HK1213926A1 (zh) |
| SG (2) | SG11201502010TA (zh) |
| WO (1) | WO2014060514A1 (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3045529B1 (en) | 2006-03-10 | 2020-07-29 | Institut Pasteur De Lille | Live attenuated bordetella strains as a single dose vaccine against whooping cough |
| EP3590532A1 (en) | 2009-04-28 | 2020-01-08 | Institut National de la Santé et de la Recherche Médicale | Vaccine for prophylaxis or treatment of an allergen-driven airway pathology |
| SG11201401904YA (en) | 2011-11-02 | 2014-05-29 | Univ Singapore | Effect of an attenuated bordetella strain against allergic disease |
| EP2722338A1 (en) | 2012-10-17 | 2014-04-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Novel recombinant Bordetella strains |
| KR101672719B1 (ko) * | 2014-07-22 | 2016-11-04 | 전남대학교산학협력단 | 바이러스 중화항원 단백질 발현을 위한 보르데텔라 백일해 균주 및 이를 이용한 면역원성 조성물 |
| US9655959B2 (en) | 2014-10-01 | 2017-05-23 | National University Of Singapore | Adenylate cyclase deficient bordetella strains |
| AU2016248452B2 (en) * | 2015-04-16 | 2018-05-31 | Inventprise, Inc. | Bordetella pertussis immunogenic vaccine compositions |
| US10682377B2 (en) | 2016-03-29 | 2020-06-16 | Institut Pasteur De Lille | Mutant Bordetella strains and methods of use |
| EP3697439A1 (en) | 2017-10-18 | 2020-08-26 | Institut Pasteur de Lille | Bordetella strains expressing serotype 3 fimbriae |
| EP3906049A1 (en) * | 2019-01-04 | 2021-11-10 | Boehringer Ingelheim Animal Health USA Inc. | Attenuated bordetella bronchiseptica strains, oral vaccines containing the attenuated strains, and methods of making & use thereof |
| EP3909971A1 (en) | 2020-09-28 | 2021-11-17 | Institute of Life Sciences (ILS) | Whole cell livestock vaccine for respiratory diseases |
| US11986499B2 (en) * | 2020-11-17 | 2024-05-21 | Iliad Biotechnologies, Llc | Treatment and prevention of neuropathology associated with neurodegenerative diseases |
| CN113429188B (zh) * | 2021-06-18 | 2022-06-10 | 湖北沛高环保科技有限公司 | 一种尾矿固废综合处理利用方法 |
| CN116265584A (zh) * | 2021-12-17 | 2023-06-20 | 远大赛威信生命科学(南京)有限公司 | 百日咳抗原重组表达载体及其工程菌和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6713072B1 (en) | 1987-11-02 | 2004-03-30 | Chiron S.R.L. | Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
| GB9115332D0 (en) * | 1991-07-16 | 1991-08-28 | Connaught Lab | Manipulation of gene copy number in bordetella |
| FR2718750B1 (fr) | 1994-04-19 | 1996-06-14 | Pasteur Institut | Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants. |
| FR2728170A1 (fr) * | 1994-12-15 | 1996-06-21 | Pasteur Institut | Vaccin de type acellulaire anti-bordetella |
| FR2754543B1 (fr) | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
| FR2840319B1 (fr) | 2002-05-30 | 2004-08-20 | Pasteur Institut | Souches de bordetella rendues deficientes par attenuation genetique |
| EP1617805A4 (en) | 2003-04-11 | 2012-07-04 | Medimmune Llc | METHODS FOR PREVENTING OR TREATING RESPIRATORY CONDITIONS |
| EP3045529B1 (en) * | 2006-03-10 | 2020-07-29 | Institut Pasteur De Lille | Live attenuated bordetella strains as a single dose vaccine against whooping cough |
| EP2069503B1 (en) | 2006-11-15 | 2016-01-06 | Folia Biotech Inc. | Papaya mosaic virus-based vaccines for influenza |
| CN101790534A (zh) | 2007-06-18 | 2010-07-28 | 半球生物制药公司 | 使用免疫活性剂的病毒感染早期干预 |
| JP2011116659A (ja) * | 2008-03-13 | 2011-06-16 | Chemo-Sero-Therapeutic Research Inst | 組換え皮膚壊死トキソイドを含有する豚萎縮性鼻炎用薬剤 |
| EP3590532A1 (en) | 2009-04-28 | 2020-01-08 | Institut National de la Santé et de la Recherche Médicale | Vaccine for prophylaxis or treatment of an allergen-driven airway pathology |
| JP5551774B2 (ja) | 2009-06-15 | 2014-07-16 | ナショナル ユニヴァーシティー オブ シンガポール | インフルエンザワクチン、組成物、および使用方法 |
| SG11201401904YA (en) | 2011-11-02 | 2014-05-29 | Univ Singapore | Effect of an attenuated bordetella strain against allergic disease |
| EP2722338A1 (en) | 2012-10-17 | 2014-04-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Novel recombinant Bordetella strains |
-
2012
- 2012-10-17 EP EP12306279.6A patent/EP2722338A1/en not_active Withdrawn
-
2013
- 2013-10-17 AU AU2013333928A patent/AU2013333928B2/en active Active
- 2013-10-17 ES ES18194351T patent/ES2771675T3/es active Active
- 2013-10-17 CA CA2887055A patent/CA2887055C/en active Active
- 2013-10-17 ES ES13777082T patent/ES2715651T3/es active Active
- 2013-10-17 CN CN201380053317.5A patent/CN104936976B/zh active Active
- 2013-10-17 EP EP18194351.5A patent/EP3459966B1/en active Active
- 2013-10-17 WO PCT/EP2013/071724 patent/WO2014060514A1/en active Application Filing
- 2013-10-17 JP JP2015537248A patent/JP6473086B2/ja active Active
- 2013-10-17 DK DK13777082.2T patent/DK2909229T3/en active
- 2013-10-17 EP EP13777082.2A patent/EP2909229B1/en active Active
- 2013-10-17 SG SG11201502010TA patent/SG11201502010TA/en unknown
- 2013-10-17 CN CN201911071187.3A patent/CN110923181A/zh active Pending
- 2013-10-17 SG SG10201706392YA patent/SG10201706392YA/en unknown
- 2013-10-17 DK DK18194351.5T patent/DK3459966T3/da active
-
2015
- 2015-04-09 US US14/682,155 patent/US9528086B2/en active Active
-
2016
- 2016-02-23 HK HK16101999.1A patent/HK1213926A1/zh unknown
-
2019
- 2019-01-24 JP JP2019009851A patent/JP6914976B2/ja active Active
-
2021
- 2021-07-14 JP JP2021116104A patent/JP7277516B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9528086B2 (en) | 2016-12-27 |
| EP3459966A1 (en) | 2019-03-27 |
| CA2887055C (en) | 2023-03-21 |
| EP3459966B1 (en) | 2019-11-27 |
| EP2909229B1 (en) | 2018-12-12 |
| JP6914976B2 (ja) | 2021-08-04 |
| ES2715651T3 (es) | 2019-06-05 |
| CA2887055A1 (en) | 2014-04-24 |
| SG10201706392YA (en) | 2017-09-28 |
| EP2909229A1 (en) | 2015-08-26 |
| JP7277516B2 (ja) | 2023-05-19 |
| DK2909229T3 (en) | 2019-03-25 |
| AU2013333928A1 (en) | 2015-04-09 |
| JP2015536134A (ja) | 2015-12-21 |
| US20150210978A1 (en) | 2015-07-30 |
| JP6473086B2 (ja) | 2019-02-20 |
| CN104936976B (zh) | 2019-11-22 |
| WO2014060514A1 (en) | 2014-04-24 |
| JP2021164481A (ja) | 2021-10-14 |
| EP2722338A1 (en) | 2014-04-23 |
| AU2013333928B2 (en) | 2017-11-30 |
| ES2771675T3 (es) | 2020-07-06 |
| SG11201502010TA (en) | 2015-04-29 |
| CN104936976A (zh) | 2015-09-23 |
| DK3459966T3 (da) | 2020-02-17 |
| JP2019088303A (ja) | 2019-06-13 |
| CN110923181A (zh) | 2020-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1213926A1 (zh) | 新穎重組博德特氏菌菌株 | |
| ZA201406525B (en) | N-cycl ylamides as nematicides | |
| EP2836211A4 (en) | NOVEL PROCEDURE | |
| HK1204797A1 (zh) | 新穎的抗- 抗體 | |
| PL2647387T3 (pl) | Kompozycja szczepionki | |
| HK1211486A1 (zh) | 新用途 | |
| GB201216800D0 (en) | Novel use | |
| IL237740A0 (en) | Recombinant organisms | |
| GB201200707D0 (en) | Composition | |
| ZA201406703B (en) | Improved injections | |
| EP2878295A4 (en) | COMPOSITION | |
| GB201208290D0 (en) | Saco | |
| EP2837670A4 (en) | COMPOSITION CONTAINING FLUOROBIPHENYL | |
| GB201206035D0 (en) | Composition | |
| EP2910538A4 (en) | AGENT COMPOSITION GENERATING GAS | |
| EP2910537A4 (en) | AGENT COMPOSITION GENERATING GAS | |
| GB2500883B (en) | Improved saw-horse | |
| GB201209597D0 (en) | Composition | |
| GB201208133D0 (en) | Composition | |
| GB201223114D0 (en) | Novel peptide | |
| GB201201720D0 (en) | Novel combinations | |
| GB201222528D0 (en) | Novel uses | |
| GB201222391D0 (en) | Novel Uses | |
| AU4878P (en) | MiniMaca Macadamia tetraphylla | |
| GB201207154D0 (en) | Novel form |